Live feed19:05:00·1511dPRReleasevia QuantisnowMyriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast CancerByQuantisnow·Wall Street's wire, on your screen.MYGN· Myriad Genetics Inc.Health Care
